Drugs / DNA-C CN54ENV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02589795 | Aug 2016 → Dec 2017 | HIV infectious disease | Imperial College London | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DNA-C CN54ENV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02589795 ↗ |
| Modality | Vaccine | “deoxyribonucleic acid (DNA) vaccine (DNA-C CN54ENV)” NCT02589795 ↗ |